Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Neuromuscular Disorders : NMD|July 15, 2023
Psychopharmaceutical treatment for neurobehavioral problems in Duchenne muscular dystrophy: a descriptive study using real-world dataPien M M Weerkamp, Sam Geuens, Philippe Collin, et al.
Neuromuscular Disorders : NMD|November 10, 2024
Genotype and corticosteroid treatment are distinctively associated with gray matter characteristics in patients with Duchenne muscular dystrophySam Geuens, Jeroen Van Dessel, Hermien E Kan, et al.
Developmental Medicine and Child Neurology|October 27, 2023
Reference curves of motor function outcomes in young steroid-naïve males with Duchenne muscular dystrophyJasmine Hoskens, Marianela Schiava, Nathalie Goemans, et al.
Neurology|July 3, 2020
Suitability of external controls for drug evaluation in Duchenne muscular dystrophyNathalie Goemans, James Signorovitch, Gautam Sajeev, et al.
Plos One|March 18, 2025
Longitudinal trajectories of muscle impairments in growing boys with Duchenne muscular dystrophyInes Vandekerckhove, Marleen Van den Hauwe, Tijl Dewit, et al.
Stem Cell Reports|January 29, 2022
Human iPSC model reveals a central role for NOX4 and oxidative stress in Duchenne cardiomyopathyRobin Duelen, Domiziana Costamagna, Guillaume Gilbert, et al.
Plos One|September 3, 2020
Muscle weakness has a limited effect on motor control of gait in Duchenne muscular dystrophyInes Vandekerckhove, Nathalie De Beukelaer, Marleen Van den Hauwe, et al.
Neuromuscular Disorders : NMD|March 26, 2011
Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: results from a 12 month, double-blind, randomized placebo-controlled trialGunnar M Buyse, Nathalie Goemans, Marleen van den Hauwe, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|April 27, 2007
CINRG pilot trial of oxatomide in steroid-naïve Duchenne muscular dystrophyGunnar M Buyse, Nathalie Goemans, Erik Henricson, et al.
Pageof 11